期刊文献+

早期浸润性乳腺癌前哨淋巴结、非前哨淋巴结转移的危险因素分析 被引量:5

Risk factors of sentinel lymph node and non-sentinel lymph node metastasis in early invasive breast cancer
下载PDF
导出
摘要 目的分析早期浸润性乳腺癌患者前哨淋巴结(SLN)、SLN转移患者非前哨淋巴结(NSLN)转移的相关危险因素,为建立SLN、SLN转移患者NSLN转移的预测模型提供依据。方法回顾性分析2014年1月至2018年12月嘉兴市妇幼保健院收治的成功行前哨淋巴结活检(SLNB)的542例早期浸润性乳腺癌患者的临床病理资料,进行单因素及多因素logistic回归分析,筛选SLN转移的危险因素、SLN转移患者NSLN转移的危险因素。结果单因素分析结果显示:病理肿瘤大小、脉管癌栓(LVI)、雌激素受体(ER)状态、孕激素受体(PR)状态均是影响SLN转移的危险因素(均P<0.05);病理类型、LVI、SLN转移数均是影响SLN转移患者NSLN转移的危险因素(均P<0.05)。年龄、肿块位置、乳房手术方式、组织学分级、人表皮生长因子受体2(HER2)状态、细胞增殖指数(Ki-67)、分子分型均与SLN转移、SLN转移患者NSLN转移无关(均P>0.05)。多因素logistic回归分析结果显示:病理肿瘤大小(OR=2.12,95%CI:1.12~3.57,P<0.01)、LVI(OR=3.77,95%CI:1.94~7.31,P<0.01)是影响SLN转移的独立危险因素;非浸润性导管癌(Non-IDC)(OR=7.20,95%CI:1.48~34.94,P<0.05),SLN转移数≥3枚(OR=10.74,95%CI:1.80~64.07,P<0.01)是影响SLN转移患者NSLN转移的独立危险因素。结论病理肿瘤大小、LVI可以作为预测早期浸润性乳腺癌SLN转移的指标;病理类型、SLN转移数可以作为预测SLN转移患者NSLN转移的指标。肿瘤直径大、伴LVI的乳腺癌患者应更加谨慎选择单纯行SLNB;有SLN转移的Non-IDC患者或SLN转移数≥3枚建议常规行腋窝淋巴结清扫。 Objective To investigate the risk factors of sentinel lymph node(SLN)metastasis in patients with early invasive breast cancer and the risk factors of non-sentinel lymph node(NSLN)metastasis in patients with SLN metastasis.Methods The clinicopathological data of 542 patients with early invasive breast cancer who underwent successful sentinel lymph node biopsy(SLNB)in Jiaxing University Affiliated Women and Children Hospital from January 2014 to December 2018 were retrospectively analyzed.The risk factors of SLN metastasis and the risk factors of NSLN metastasis in patients with SLN metastasis were examined by univariate and multivariate Logistic regression analyses.Results Univariate analysis showed that pathological tumor size,lymphovascular invasion(LVI),estrogen receptor(ER)status and progesterone receptor(PR)status were significantly correlated with SLN metastasis(P<0.05),while pathological type,LVI and number of metastasized SLNs were significantly correlated with NSLN metastasis(P<0.05).However,age,tumor location,breast surgical procedure,histological grade,human epidermal growth factor receptor 2(HER2)status,cell proliferation index(Ki67)expression,and molecular typing were not correlated with SLN metastasis or NSLN metastasis in patients with SLN metastasis(P>0.05).Multivariate analysis showed that pathological tumor size(OR:2.12,95%CI:1.12-3.57,P<0.01)and LVI(OR:3.77,95%CI:1.94-7.31,P<0.01)were independent risk factors of SLN metastasis.Non-invasive ductal carcinoma(non-IDC)(OR:7.20,95%CI:1.48-34.94,P<0.05)and sentinel metastasis≥3(OR:10.74,95%CI:1.80-64.07,P<0.01)were independent risk factors for NSLN metastasis in patients with SLN metastasis.Conclusion Pathological tumor size and LVI can be used as indicators to predict SLN metastasis in early invasive breast cancer.Pathological types and the number of metastasized SLNs can be used as indicators to predict NSLN metastasis in patients with SLN metastasis.SLNB should be chosen more carefully for breast cancer patients with large tumor diameter and LVI.
作者 蔡李芬 朱晓萍 唐婕 朱娟英 CAI Lifen;ZHU Xiaoping;TANG Jie;ZHU Juanying(Department of Breast,Jiaxing University Affiliated Women and Children Hospital,Jiaxing 314000,China)
出处 《浙江医学》 CAS 2021年第6期582-588,共7页 Zhejiang Medical Journal
基金 浙江省医药卫生科技计划项目(2018PY070)。
关键词 乳腺癌 前哨淋巴结 非前哨淋巴结 转移 危险因素 Breast cancer Sentinel lymph node positive Non-sentinel lymph nodes Metastasis Risk factors
  • 相关文献

参考文献14

二级参考文献126

  • 1王晨,张晓琴,魏荣,吴丽然,李欣.乳腺癌淋巴结转移相关因素的多元分析[J].山西医药杂志,2006,35(12):1068-1072. 被引量:5
  • 2Giuliano AE,Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer [J]. Ann Surg ,1994,220(3) :391 - 401. 被引量:1
  • 3Turner RR,Ollila DW, Krasne DL,et al. Histopathologic validation of the sentinel lymph node hypothesis for breast earcinoma[J]. Ann Surg, 1997,226(3) :271 - 278. 被引量:1
  • 4Lyman GH,Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early stage breast cancer [J]. J Clin 0ncol,2005,23(30) :7703 - 7720. 被引量:1
  • 5Kamath V,Giuliano R,Dauway E,et al. Characteristics o the sentinel lymph node in breast cancer predict further involvement o1[ higher echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection[J]. Arch Surg ,2001,136(6) :688 - 692. 被引量:1
  • 6Stitzenberg KB, eyer AA, Stern SL, et al. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden [J]. Ann Surg,2003,237(5) :607 - 612. 被引量:1
  • 7Kim T,Giuliano A_E, Lyman G H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma : a meta-analysis [ J ]. Cancer, 2006, 106 ( 1 ) : 4 - 16. 被引量:1
  • 8Van Zee K, Manasseh DE, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastasis in breast cancer patients with a positive sentinel node biopsy[J]. Ann Surg Oncol, 2003,10( 10): 1140- 1151. 被引量:1
  • 9Barranger E, Coutant C, Flahault A, et al. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis[J]. Breast Cancer Res Treat ,2005,91 (2) : 113 - 119. 被引量:1
  • 10Goldhirsch A, Winer EP, Coates AS, e! al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013[J]. Ann Onco1,2013,24(9) :2206 - 2223. 被引量:1

共引文献101

同被引文献57

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部